Consultation on testing proposals under Article 40(2) of UK REACH for the following substances (deadline 30 September 2021)

2021-08-17

2-ethylhexyl 10-ethyl-4,4-dimethyl-7-oxo-8-oxa-3,5-dithia-4-stannatetradecanoate

1-(4-(acetyloxy)-3-((acetyloxy)methyl)phenyl)ethenone

Hexyl salicylate

2,2-dimethyl-3-oxopropyl dodecanoate

HSE has received proposals to undertake testing in vertebrates to consider and evaluate.

Article 40(2) of the UK REACH Regulation requires HSE to invite third parties to submit scientifically valid information and studiesthat are relevant to proposed vertebrate tests. These submissions will be considered and evaluated alongside the proposals submitted by the registrants.

Any interested third parties are invited to provide such information and studies that address the substances and hazard endpoints below for which testing is proposed. Information can be submitted by any member of the public or interested party.

Consultation details for the endpoints for which testing is proposed can be viewed by following the links below:

Genetic toxicity in vivo

1-(4-(acetyloxy)-3-((acetyloxy)methyl)phenyl)ethenone Genetic toxicity in vivo

Sub-chronic toxicity (90-day): oral Reproductive toxicity (pre-natal developmental toxicity)

2,2-dimethyl-3-oxopropyl dodecanoate Long term toxicity to fish

Scientific and technical information relevant to the testing proposals should be submitted directly to HSE using the commenting webform and templates by 1 October 2021.

Read More

HSE, 17 August 2021
; https://www.hse.gov.uk/reach/